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We r- The National Cancer Institute (NCI) and
Q¢liii~ity sIZ4dat int-"-i S*~d fl*s ~the National Toxicology Program (NTP)
have designed, carried out, and evaluated
.-.-.-.,,.,, ,-,-, e... ...
~.more than 400 long-term carcinogenicity
malet u ig. studies in laboratory rodents (1-3). The
purpose of these studies is to identify
-o prod-we thene:tame chemicals that may pose a carcinogenic
hazard to humans. The results of these
cerm 5flUSp' Studies have been presented in a series of
~technical reports and in the scientific liter-
~ ~ ~ ~ atre. These data are used by the interna-
tional scientific community and by various
:~ governmental agencies in making regulato-
Ms: :::::::>sss:ss:::decisionsaffecting public health.
cinogenic The focus of the NCI/NTP studies is
preFItttl/.h . evaluation and interpretation of site-
cific carcinogenic effects (4) A recent
~publication (2) presented a tabular sum-
mary of site-specific carcinogenicity results
d.n. .....e..e for 379 NCI/NTP studies. The purpose
~of this paper is to investigate correlations
'''z-.K--pA¢ .......................
'S''''"""""''tichemically relat site-specific carcino-
....Le....genic responses in this database both with-
in and between species for a variety of dif-
::s* sssssssstwe ferent target sites.
....Other investigators have considered
certain aspects of these associations. For
example, Gold et al. (5,6) investigated the
predictive value of site-specific carcino-
in- sodt rygenic responses for chemicals in the
a~~Carcinogenic Potency Database. Their
h'.~~~~~~~evaluation differed from ours in that their
site-specific analyses involved primarily the
same target site in the other species, and
the evaluation used data from a variety of
isens-it-vi kms sources and thus included studies that did
not employ the standardized protocol used
~by the NCI/NTP.
The primary objective of our investiga-
pteuncoid--is tion is to identify associations between site-
-- AX SSeSS ma y o sspecificcarcinogenic effects that may
kn~ increase our understanding of the value
and limitations of long-term rodent stud-
IOI1)~ ies. The implication of these associations
.,.,.,g,".,,................5°_SS''"
on the possible use of a reduced protocol
for rodent carcinogenicity evaluation is
also discussed.
-........ . ..
...Methods
SSS::.......................................
... .......The carcinogenicity database used in our
'" ......S..... .........SS
........................... eanalysis consisted of the 379 long-term
-wet--s-XbsssEsssX-^esX- gNCI/T rstudies inorat
.............. s s ° a s ssss s oa:
-~~~~~~~~~ sNCsss SS S:S .SSSSS L IT stuie In rat an/o mic conr
sidered by Huffet al. (2). The site-specific
carcinogenic effects observed in each
sex-species group were evaluated for possi-
ble associations. The specific target organs
used in our evaluation were the 13 most
frequent sites of carcinogenicity in these
studies (Table 1). Overall, 89% ofthe rat
carcinogens and 91% of the mouse car-
cinogens in the NCI/NTP database pro-
duced carcinogenic effects in at least one of
these sites.
Initially, experimental outcomes were
divided into three categories: positive,
negative, and equivocal. To simplify the
analysis, equivocal outcomes were subse-
quently combined with negative results,
because in our judgment chemicals pro-
ducing equivocal effects are closer to being
negative than positive (7). However, alter-
native analyses (results not shown) in
which equivocal responses were considered
positive or were excluded altogether pro-
duced similar results to those reported in
this paper.
We considered several types of associa-
tions: first, for each target site, we evaluat-
ed the correlation in carcinogenic response
between males and females within a species
for those studies with adequate experi-
ments in both sexes. Second, we evaluated
correlations between species for a given tar-
get site for those 313 studies with experi-
ments adequate for evaluating carcino-
genicity in all four sex-species groups. In
these analyses, a species was considered
positive if a carcinogenic response was
observed in males, in females, or in both
sexes. Finally, we evaluated correlations
between different target sites both within
and between species. Our analyses includ-
ed noncarcinogens as well as carcinogens.
The strengths of the associations were
assessed by Fisher's exact test. Because the
analyses involved a large number of com-
parisons, p<0.01 (rather thanp<0.05) asso-
ciations were considered significant. This
reduces the likelihood offalse positive out-
comes.
Results
Within a species, most target sites showed
a significant correlation between males and
females with respect to site-specific car-
cinogenic responses. Table 2 summarizes
the most striking of these associations for
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Table 1. Site-specific carcinogenic effects observed in 379 NTP studies
No. ofstudies
with carcinogenic effects
Site of carcinogenicity Rats Mice Rats or mice
Liver 44 86 104
Lung 9 23 30
Hematopoietic system 17 15 29
Kidney (tubular cell) 24 4 27
Mammary gland 22 9 27
Forestomach 15 17 23
Thyroid gland (follicular cell) 16 9 18
Zymbal gland 18 2 18
Urinary bladder 14 4 16
Skin 15 3 15
Clitoral/preputial gland 11 3 14
Circulatory system 4 11 13
Adrenal gland (pheochromocytoma) 5 6 11
Table 2. Sites showing significant (p<0.0001) correlation between males and females for chemically
related carcinogenicity
Carcinogenicity outcome
(male/female)
Site of carcinogenicity +/+ +/- -/+
Rats
Liver 26 11 5 307
Zymbal gland 13 3 2 331
Forestomach 11 4 0 334
Thyroid (follicular cell) 10 3 3 333
Urinary bladder 6 4 4 335
Skin 6 8 1 334
Clitoral/preputial gland 5 1 5 338
Lung 3 2 4 340
Mice
Liver 47 11 28 253
Lung 16 2 4 317
Forestomach 14 1 1 323
Thyroid (follicular cell) 5 1 3 330
Circulatory system 6 2 3 328
Adrenal medulla 3 2 1 333
Table 3. Interspecies correlation in carcinogenic response for selected target sites
Carcinogenicity outcome
(rat/mouse)
Site ofcarcinogenicity +/+ +/- -/+
Significant(p<0.001) correlation
Liver 25 8 53 227
Forestomach 8 6 7 292
Thyroid gland 7 9 2 295
Mammary gland 4 14 3 292
All sitesa 82 40 40 151
No significant correlation
Lung 2 5 16 270
Adrenal medulla 0 4 4 305
Preputial/clitoral gland 0 7 3 303
aTaken from Huff et al. (2).
the 349 rat studies and the 339 mouse
studies with adequate experiments for both
sexes.
The greatest consistency was found for
the forestomach. For example, in rats, all
11 studies showing forestomach carcino-
genicity in female rats also showed these
effects in males rats (Table 2). Similarly,
in mice, 14 ofthe 15 studies showing car-
cinogenic forestomach effects in one sex
also showed similar effects in the other sex
(Table 2). Other sites showing a strong
consistency between males and females
include liver (rats and mice), Zymbal gland
(rats), and lung (mice). In contrast, mam-
mary gland tumors showed relatively low
association between males and females
because they were induced almost exclu-
sively in females. Also, there were far more
carcinogens that produced kidney tumors
in male rats than in female rats.
There was also a strong correlation
between species for certain site-specific car-
cinogenic effects. For example, a chemical
carcinogenic to the liver of male and/or
female rats was four times more likely to be
a mouse liver carcinogen than was a chemi-
cal not carcinogenic to rat liver (76% =
25/33 versus 19% = 53/280; see Table 3).
In analogous comparisons, the correspond-
ing probabilities for forestomach, thyroid,
and mammary gland tumors were 57%
versus 2%, 44% versus 1%, and 22% ver-
sus 1%, respectively (Table 3). All ofthese
differences are highly significant
(p<o.oo1).
Equally interesting were the sites show-
ing no significant correlation between
species. For example, there were no chem-
icals in the database that produced adrenal
pheochromocytoma or preputial/clitoral
gland tumors in both rats and mice (Table
3). The lung was another site showing no
significant interspecies correlation in
chemically related carcinogenicity: only 2
ofthe 23 chemicals producing lung tumors
showed these effects in both rats and mice
(Table 3). Ifall target sites are considered
collectively, the overall interspecies concor-
dance in carcinogenic response is 74%
(233/313; see Table 3). This interspecies
association is consistent with other pub-
lished estimates (5,8).
Within a sex-species group, certain tar-
get sites tended to show carcinogenic
effects for the same chemicals. For exam-
ple, in rats, tumors of the skin, Zymbal
gland, preputial/clitoral gland, and (to a
lesser extent) mammary gland were inter-
correlated (Table 4). Eight chemicals (C.I.
acid red 114, C.I. direct blue 15, 3,3'-
dimethylbenzidine dihydrochloride, 3,3'
dimethylbenzidine dihydrochloride, 2,4-
diaminoanisole sulfate, glycidol, 5-nitroa-
cenaphthene, and 5-nitro-o-anisidine)
produced carcinogenic effects at 4/4 or 3/4
of these sites, and 8 other chemicals [3-
amino-9-ethylcarbazole HCI, benzene, C.I.
basic red 9, 2,4-dinitrotoluene, 3,3'-
dimethoxybenzidine-4,4 '-diisocynate,
hydrazobenzene, nithiazide, and tris(azi-
ridinyl)-phosphine sulfide] produced effects
at 2/4 ofthese sites.
Two other target sites that showed an
association both within and across species
were liver and thyroid gland. The likeli-
hood of a chemical being a rodent liver
carcinogen was much higher for those
chemicals that were thyroid follicular cell
carcinogens than for those chemicals that
were not (Table 5). Forexample, ofthe 18
chemicals showing thyroid carcinogenicity
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Table 4. Significant (p<0.01) correlation in chemically related carcinogenic effects for skin, Zymbal gland,
preputial/clitoral gland, and mammary gland tumors in rats
Carcinogenicity outcome
Sites ofcarcinogenicity +/+ +/- -/+ -/-
Skin/Zymbal gland 12 3 6 328
Skin/preputial-clitoral gland 7 8 4 330
Skin/mammary gland 5 10 17 317
Zymbal/preputial-clitoral gland 8 10 3 328
Zymbal/mammary gland 5 13 17 314
Preputial/clitoral/mammary gland 4 7 18 320
Table 5. Correlation in chemically related carcinogenic effects for liver neoplasms and thyroid gland fol-
licular cell tumors in rats and mice
Carcinogenicity outcome
Sites of carcinogenicity +/+ +/- -/+
Rat liver/ratthyroid 6 36 10 297
Rat liver/mouse thyroid 5 28 4 276
Mouse liver/ratthyroid 10 68 6 229
Mouse liver/mouse thyroid 7 79 2 251
Rodent liver/rodentthyroid 11 75 7 220
All associations are significant atthe p<0.01 level. Rodent = rat or mouse.
Table 6. Other significant (p<0.001) correlations between sites in chemically related carcinogenicity
Carcinogenicity outcome
Sites of carcinogenicity +/+ +/- -/+
Rat liver/ratZymbal gland 9 33 9 298
Mouse liver/mouse adrenal medulla 6 80 0 253
Mouse lung/mouse hematopoietic 6 16 8 309
Mouse lung/mouse mammary gland 7 15 2 315
Mouse lung/mouse forestomach 7 15 9 308
Mouse lung/rat mammary gland 7 11 11 284
in rats or mice, 61% (11/18) also produced
liver tumors in one or both species. In
contrast, for those chemicals not producing
thyroid follicular cell tumors, only 25%
(75/295) produced rodent liver tumors.
This association between liver and thyroid
neoplasms has been previously noted (9).
There were relatively few other notable
correlations between different sites of car-
cinogenicity, and the most significant of
these are summarized in Table 6.
Chemically related lung tumors in mice
were associated with forestomach and
hematopoietic system tumors in mice and
with mammary gland tumors in both rats
and mice. All six chemicals producing
adrenal pheochromocytomas in mice were
also mouse liver carcinogens. Liver and
Zymbal gland tumors in rats were also cor-
related.
Kidney and urinary bladder tumors in
rats showed no significant association with
any other tumor type in rats or mice.
Circulatory system tumors in mice did not
show strong associations with other tumor
types. Interestingly, there were no signifi-
cant negative correlations in chemically
related site-specific carcinogenic responses
in the database. That is, there were no tar-
get sites for which chemicals producing
carcinogenic effects at that site were signifi-
cantly less likely to produce carcinogenic
effects at another site.
Although mesotheliomas were not part
ofour primary analysis because ofthe rela-
tively low frequency of carcinogenic
effects, it is noteworthy that all six chemi-
cals producing mesothelioma in male rats
(cytembena, 1,2-dibromoethane, 3,3'-
dimeoxybenzidine dihydrochloride, 3,3'-
dimethylbenzidine dihydrochloride, glyci-
dol, and O-toluidine hydrochloride) also
produced mammary gland tumors in fe-
male rats. This association is highly signif-
icant (p<0.0001).
Another tumor site that was not part of
our primary analysis was oral cavity, which
showed chemically related neoplastic
effects for eight chemicals in rats (none in
mice). These tumors are strongly associat-
ed with the skin-Zymbal gland-clitoral/pre-
putial gland-mammary gland "syndrome"
noted in Table 4: 6/8 chemicals produc-
ing oral cavity tumors in rats also produced
2 or more of the other tumors in the syn-
drome.
Approximately 10% (32/313) of the
chemicals adequately evaluated in all four
sex-species groups produced single site,
single sex-species carcinogenic effects.
The organs most often involved were liver
(five chemicals for female mice; four for
male mice) and kidney (four for male rats).
Approximately 58% of the carcinogens in
the NTP database are positive in
Salmonella, compared to 30% of the non-
carcinogens (10). Gold et al. (11) found
similar results for chemicals in the
Carcinogenic Potency Database. Both
investigators (10,11) reported that multi-
site carcinogenicity was associated with
Salmonella mutagenicity, a finding consis-
tent with our own evaluation. For exam-
ple, consider the chemicals that produced
the multisite syndrome of carcinogenic
effects noted in Table 4. Ofthe 16 chemi-
cals showing site-specific effects in at least
2 ofthe 4 target sites (skin, Zymbal gland,
clitoral/preputial gland, and mammary
gland) all but 2 (benzene and C.I. direct
blue 15) were positive in Salmonella.
Similarly, all six chemicals producing
mesotheliomas in male rats and mammary
gland tumors in female rats were positive
in Salmonella.
In contrast, chemicals producing kid-
ney tumors (which were not associated
with other tumor types) tended to be non-
mutagens. Ofthe 25 chemicals producing
male rat kidney tumors, only 28% (7/25)
were mutagenic in Salmonella. Further,
only 31% (4/13) of the chemicals noted
above with single sex-species liver or kid-
ney tumor effects were mutagenic in Sal-
monella. These percentages are similar to
those observed for the noncarcinogens in
the database.
Among the liver carcinogens in the
database, 70% (16/23) of the chemicals
that produced these neoplasms in both
species were mutagenic in Salmonella com-
pared to only 30% (7/23) for those chemi-
cals whose only carcinogenic effect was
liver tumors in mice (2,12). This differ-
ence in Salmonella mutagenicity (70% ver-
sus 30%) is statistically significant
(p<0.05). One possible explanation for
this difference is that a relatively high pro-
portion of mouse-liver-only carcinogens
are chlorinated compounds, which tend to
be nonmutagenic (5,11).
Our evaluation also permits a compari-
son of the male-female correlation with
the interspecies association in site-specific
carcinogenicity. This evaluation is sum-
marized in Table 7. Although the inter-
species correlation varies for each site of
carcinogenicity, ifthe 13 major target sites
are considered collectively, the overall
probability is 35% (61/173) that a site-spe-
cific carcinogenic effect in rats will also be
produced by that chemical in mice at the
same site (Table 7). Similarly, 37%
(61/167) of the site-specific carcinogenic
effects in mice are also produced by the
same chemical in rats (Table 7).
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Table 7. Correlations in site-specific carcinogenicity: proportion of chemicals carcinogenic in the first
sex-species group that are also carcinogenic atthat site in the second sex-species group
Site of carcinogenicity
Liver
Lung
Hematopoietic system
Kidney (tubular cell)
Mammary gland
Forestomach
Thyroid gland
Zymbal gland
Urinary bladder
Skin
Clitoral/preputial gland
Circulatory system
Adrenal medulla
Total
Female rats/
male rats
26/32
3/7
5/9
6/7
3/22
11/11
10/13
13/15
6/10
6/7
5/10
2/2
1/1
97/146
(66%)
Female mice/
male mice
47n5
16/20
6/12
1/1
0/9
14/15
5/8
1/2
2/2
2/2
0/0
6/9
3/4
103/159
(65%)
Rats/mice
25/33
2/7
3/14
3/21
4/18
8/14
7/16
2/12
2/12
3/11
o0
2/4
0/4
61/173
(35%)
Mice/rats
25/8
2/18
3/11
3/4
4/7
8/15
7/9
2/2
2/3
3/3
0/3
2/10
0/4
61/167
(37%)
Table 8. Rodent carcinogens not detected by a reduced protocol of male rats and female mice
Chemical
Aldrin
Allyl glycidol ether
3-Amino-4-ethoxyacetanilide
Chlorinated paraffins (C23, 43% chlorine)
C.l. acid orange 3
C.l. vatyellow 4
Daminozide
2,4-Diaminophenol
Dicofol
Nithiazide
3-Nitro-p-acetophenetide
Phenylbutazone
Piperonyl sulfoxide
p-Quinone dioxime
Trimethylthiourea
FR, female rats; MM, male mice.
For these same target sites, 66%
(97/146) of the site-specific carcinogenic
effects observed in female rats were also
observed in male rats (Table 7). For mice,
65% (103/159) of the site-specific effects
observed in female mice also occurred in
males. Thus, the agreement between sexes
within a species is considerably higher than
the corresponding agreement between
species.
Discussion
When evaluating associations in site-specific
carcinogenic responses, we considered all
experimental outcomes, negative as well as
positive. For example, there were 61 chemi-
cals that produced liver carcinogenicity in a
single species and 25 that produced a liver
tumor response in both rats and mice (Table
3). However, this information alone is
insufficient to evaluate interspecies correla-
tion in liver tumor carcinogenicity. Ifthere
is no interspecies correlation, the likelihood
ofobserving a mouse liver carcinogen should
Target site
Liver (MM)
Nasal cavity (MM)
Thyroid gland (MM)
Hematopoietic system (MM)
Kidney (FR)
Hematopoietic system (MM)
Uterus (FR)
Kidney(MM)
Liver(MM)
Mammary gland/skin (FR)
Liver(MM)
Liver(MM)
Kidney (FR)
Liver(MM)
Liver (MM)
Urinary bladder (FR)
Thyroid gland (FR)
be the same regardless ofwhether a chemi-
cal is a rat liver carcinogen. Thus, had there
been only 17 chemicals not carcinogenic to
the liver ofrats or mice, then the proportion
ofmouse liver carcinogens would have been
76% (25/33) for rat liver carcinogens and
76% (53/70) for chemicals not carcinogenic
to rat liver, indicating no association. How-
ever, the actual database contained 227, not
17, chemicals not carcinogenic to the liver of
either species (Table 3). Thus, only 19% of
the rat liver noncarcinogens were mouse
liver carcinogens, and this difference in
response (76% versus 19%) implies a strong
association, as noted above.
Our evaluation revealed a number oftar-
get sites showing significant associations in
chemically related carcinogenic responses
between species. However, such agreement
was far from complete, and the overall prob-
ability that a chemical carcinogenic at a par-
ticular site in rats will be carcinogenic at the
same site in mice (and vice versa) is approxi-
mately36%.
Consideration of different target sites
produced similar results. For example,
despite the significant (p<0.01) correlation
between chemically induced liver and thy-
roid tumors, the vast majority of liver car-
cinogens (in either species) did not pro-
duce thyroid tumors. Similarly, many
chemicals produced thyroid tumors with-
out increasing the incidence of liver neo-
plasms (see Table 5).
There was much better agreement be-
tween sexes within a species, and this
strong correlation in carcinogenic response
between males and females has been noted
previously (3,5,8). However, these earlier
analyses were based on overall carcino-
genicity rather than on site-specific effects.
Our evaluation shows that this same strong
correlation also holds for site-specific car-
cinogenicity.
These results may have implications for
the experimental design of long-term
rodent studies. Some investigators have
noted that from the standpoint of detect-
ing carcinogenic effects, relatively little sen-
sitivity would be lost by restricting the
study to two rather than four sex-species
groups (5,8). Because the male-female cor-
relation in carcinogenic response is much
stronger than the interspecies correlation, a
reduced protocol ofone sex ofeach species
would be more sensitive for detecting
rodent carcinogenicity than using both
sexes ofeither species. The best choice for
a reduced protocol may be male rats and
female mice (8).
For example, of the 162 NCI/NTP
chemicals adequately evaluated in all four
sex-species groups and found to be car-
cinogenic in at least one group (see Table
3), only 15 (9%) would not have been
detected as rodent carcinogens in a reduced
protocol of male rats and female mice.
These 15 chemicals, listed in Table 8, gen-
erally produce single-site, single sex-species
carcinogenic effects. Moreover, the toxici-
ties of these chemicals as measured by the
maximum tolerated dose (MTD; 13) are
somewhat lower on average than those of
the other carcinogens in the database.
More than halfofthe chemicals (8/15) are
negative in the Salmonella assay. None are
listed as "reasonably anticipated to be"
human carcinogens in the NTP Sixth
Annual Report on Carcinogens (14) or as
being "possible" or "probable" human car-
cinogens by the International Agency for
Research on Cancer (IARC). Thus, it
appears that a reduced protocol would not
miss many of the carcinogens likely to be
ofpublic health significance.
However, reduced sensitivity involves
more than not detecting carcinogens.
Many national and international organiza-
tions (e.g., LARC, the NTP in its Annual
Report on Carcinogens) generally require
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Table 9. Two-species rodent carcinogens detected as one-species carcinogens by a reduced protocol
of male rats and female mice
Carcinogenicity Number of
outcome target sites
Chemical MR FR MM FM Full Reduced
Benzofuran - + + + 4 3
Chlorendic acid + + + - 2 2
p-Chloroaniline HCI + E + - 4 2
HC blue 1 E + + + 2 1
1,2,3,6,7,8- and 1,2,3,7,8,9-HCDD E + + + 1 1
ICRF-159 - + - + 2 1
Isophosphamide - + - + 3 1
1,5-Naphthalenediamine - + + + 5 3
Nitrofurazone E + - + 2 1
p-Nitrosodiphenylamine + - + - 1 1
Phenestrin - + + + 4 3
Tetrachlorvinphos - + + + 3 1
MR, male rats; FR, female rats; MM, male mice; FM, female mice; + = carcinogenic; - = not carcino-
genic; E = equivocal carcinogenic response; full, male and female rats and mice; reduced, male rats and
female mice; HCDD; hexachloro-p-dibenzodioxin.
evidence of carcinogenicity in two species
before a chemical is considered "possibly,"
"probably," or "reasonably anticipated to
be" a human carcinogen. A reduced proto-
col would miss some of these two-species
carcinogens, declaring them to be one-
species carcinogens. For the NCI/NTP
database, 12 two-species carcinogens
would have been reduced to one-species
carcinogens using a reduced protocol of
male rats and female mice, and these
chemicals are summarized in Table 9.
Unlike the chemicals in Table 8, most
of these chemicals produced carcinogenic
effects at multiple target sites. The toxici-
ties (MTDs) ofthese chemicals were simi-
lar on average to those ofother carcinogens
in the NCI/NTP database, and half of
these chemicals that were tested in
Salmonella (4/8) were positive. Even so,
only 1 of thesel2 chemicals (chlorendic
acid) is listed in the NTP Sixth Annual
Report on Carcinogens as 1 of the 150
substances and medical treatments "reason-
ably anticipated to be [human] carcino-
gens" (14). Chlorendic acid is also the
only 1 ofthese 12 chemicals considered by
IARC to be a "possible" human carcinogen
(15).
Ifthese two types ofsensitivity loss are
considered collectively, less than 10%
(27/313) ofthe chemicals evaluated by the
NCI/NTP (17% of the carcinogens)
would have shown some sensitivity loss by
the use of a reduced protocol of male rats
and female mice. Moreover, of these 27
chemicals, only one is currently considered
by the NTP or IARC to be a likely or pos-
sible human carcinogen.
It must be noted that the NTP Annual
Report on Carcinogens (14) has exposure
and production criteria that may not have
been met by certain chemicals in Tables 8
and 9. Further, less than halfofthe chem-
icals in these two tables has been formally
evaluated by IARC in its series of mono-
graphs. Nevertheless, our evaluation sug-
gests that the carcinogens missed by using
a reduced protocol ofmale rats and female
mice may not be those chemicals most
likely to pose a carcinogenic threat to
humans.
A further consideration in the decision
ofwhether to use a reduced protocol is the
possible loss of supporting information in
one sex when interpreting results in the
other sex. That is, because ofthe high cor-
relation in carcinogenic response between
males and females, there may be instances
in which a borderline carcinogenic effect in
one sex-species group would be called pos-
itive rather than equivocal or negative
because of a similar carcinogenic effect at
that same site in the other sex of that
species. This supporting information
would be lost in a reduced protocol ofone
sex of each species. However, an evalua-
tion of the magnitude of the carcinogenic
responses in recent NCI/NTP studies sug-
gests that this type ofsensitivity loss would
not be a frequent occurrence.
The loss ofsensitivity associated with a
reduced protocol must be balanced against
the possible advantages ofevaluating more
chemicals and/or reallocating resources to
basic mechanistic studies. Although our
evaluation suggests that this more limited
experimental design is an option that may
be appropriate in some instances, the deci-
sion ofwhether to use such a reduced pro-
tocol is best made on a case-by-case basis.
In conclusion, our evaluation 1) shows
that the previously reported high
male-female and interspecies correlations
in carcinogenic response also hold for
many site-specific neoplasms, 2) identifies
significant associations in site-specific car-
cinogenic responses that may be useful in
further research efforts; and 3) suggests
that because ofthe high correlation in car-
cinogenic response between males and
females, in many cases a reduced protocol
ofone sex ofeach species may be sufficient
to detect rodent carcinogenicity.
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